Menu
Log in
Log in
LOGIN/OUT >

To support people, organisations and business to understand the value of collaboration and the benefits achieved through collaborative working.

News

  • 16 Mar 2022 4:25 PM | Adrian Wright (Administrator)

    ICW presents its First Certificate of Competence under ISO44003 to NATS and Thinking Space Systems Ltd. and confirms that their Collaborative Business Relationship meets the intent of the MSME scheme.

    John Osborn presents the ICW certificate of Competence to Paul Roberts of Thinking Space Systems Ltd watched by Darren Rowlands of NATS.

  • 16 Mar 2022 2:44 PM | Adrian Wright (Administrator)

    Tim Mowat hosted a strategy workshop for the team of ICW at Warwick university on the 1st of March.

    Tim commented on the uniqueness of ICW that it can drawer on over 500 years of combined Collaborative experience in the one team.

  • 16 Mar 2022 12:42 PM | Adrian Wright (Administrator)

    ICW welcomes 4 new members who successfully completed the ISO 44001 Leaders Course held at Warwick university from 7-10 March 2022.

    Thomas Maliet, Isabelle Bielawski, Mathew Squire and Rachel Lindy are pictured with ICW's Leigh Lawry and Warwick University's Paul Connor after successfully completing the course.

  • 16 Mar 2022 12:31 PM | Adrian Wright (Administrator)

    ICW welcomed Thomas Maliet and Isabelle Bielawski as the First Members of the Institute based in France.

    Thomas and Isabelle of Transdev - the France-based Public Transport company - both successfully completed the ISO 44001 Leaders Course held at Warwick university in March.

  • 11 Feb 2022 11:06 AM | Adrian Wright (Administrator)

    Leigh Lawry (Tutor) and Paul Connor (Adjudicator) pose with the 3 successful candidates who attended the ISO 44001 Leaders Course run by ICW at Warwick University this week.

    Congratulations to David Mason, Andy Cooper, and Peter Hayes all who passed the course and are now eligible to apply for membership of the Institute and become MICWs.

  • 12 Jan 2022 10:38 AM | Adrian Wright (Administrator)

    ESS Defence, part of Compass Group UK & Ireland, and the Defence Infrastructure Organisation (DIO) have won the Institute for Collaborative Working Service Sector Award.

    The award recognises teams that excel in improving service delivery through a collaborative approach. It marks the successful relationship between ESS and DIO in the delivery of three large Defence Soft FM contracts in the East, South West and Wales & West Midlands. The contracts, awarded under the MOD's Hestia programme, cover 240 military establishments and 100+ services, ranging from catering, retail and leisure through to waste, cleaning and laundry. The objective for both organisations is to enhance the lived experience for service personnel in the sites where they live and work.

    The Hestia programme brings together multiple ESS, DIO and military stakeholders. A structured approach to collaboration at the highest level has enabled ESS and DIO to develop and instil shared objectives, ways of working and behaviours that filter through the contracts.

    Both organisations have achieved ISO 44001 certification for the relationship which is managed by a joint ESS and DIO partnering board. The systems and processes required by the standard facilitate a consistent approach which is key to successful collaboration.

    Benefits delivered through the relationship include:

    • Ensuring colleague and customer safety through the joint development of safe operating procedures during COVID-19
    • Enhancing the lived experience through investment in food service and retail facilities, including the first fully self-service convenience store on the UK Defence estate
    • Embracing digitalisation to improve access to services through implementation of the ESS App designed specifically for Defence and Government customers
    • Focusing on sustainability across all service streams, including increasing plant-forward meal options, introducing chemical free cleaning, eliminating the top ten single use plastic products, delivering zero waste to landfill from contract start and consistently improving recycling rates
    • Supporting personal wellbeing through a detailed wellness programme designed for ESS, DIO and military colleagues.

    Mark Webster, Managing Director – ESS Defence, Energy and Government Services, commented:

    "We are delighted that our relationship with DIO has been recognised by the Institute for Collaborative Working. Both organisations are committed to working closely together for the benefit of service personnel and we have put structures in place to drive effective collaboration at all levels, from our senior leadership teams to our frontline colleagues. The partnership has delivered great things during the first four years of the Hestia programme and there is much more to come."

    Richard McKinney, Regional Delivery Director - DIO, commented:

    "Recognition by the Institute for Collaborative Working is a great achievement. We are committed to working together and collaborating; which means that we solve problems quicker, we learn from each other, and ultimately our customers get better outcomes."

    For further information please contact Compass Group UK & Ireland Communications Team on 01895 554 999 or email uk.communications@compass-group.co.uk

  • 23 Dec 2021 10:44 AM | Adrian Wright (Administrator)

    ICW confirmed Fellowships on five of its members at the ICW 2021 Awards Event on the 16th of December.

    The event was due to be held at the House of Lords but due to the Covid restrictions being extended by the Palace of Westminster it was transferred online.

    Jo Potter, the chair of the Professional Development SIG who chaired the interview panel of Fellows early in the Month announced the following recipients.

    Nicky Painter

    Nicky is one of the longest serving members of ICW since the days of Partnership Sourcing. Over those years she has been an active associate undertaking a variety of projects in support of the Institutes goals including the early days of our individual membership production of the Partner and always there when we needed help.

    Andrew Hopper

    Andrew has been an enthusiastic supporter of the Institute for a number of years working through Skanska and the wider industry to promote collaborative working. His energy has been invaluable to the development of some of our Special Interest Groups.

    Leigh Lawry

    As one of ICW's Associate Directors Leigh has been a great champion of collaborative working and principal Tutor for both BSI courses delivered by ICW and the ICW Leaders course where he has been acknowledged by all for his dedication and support.

    Lois Love

    A tireless supporter of ICW and champion for our younger members Lois though both the advisory Council and her work alongside Jo Potter in the development of our Professional development special interest group in the creation of our recently launched mentoring scheme.

    Leigh Verrall

    Leigh as the product lead for BSI of ISO 44001 her expertise in the field of standards has been recognised by many within ICW and organisations striving to enhance their collaborative capability together her contribution as BSI corporate representative on the Advisory council.

  • 30 Nov 2021 2:39 PM | Adrian Wright (Administrator)
    Projects by their very nature require many stakeholders to work together to deliver outcomes. The greater the level of collaboration the higher the probability of success. This webinar was held on 23 November 2021.
    Read the full article on apm.org.uk
  • 29 Nov 2021 4:00 PM | Adrian Wright (Administrator)
    What an 18 months it has been! The UK's life sciences sector has come into its own leading society out of the pandemic, with tremendous opportunities through innovation and collaboration which can be applied for a better future for all.

    The UK has taken the lead with the Oxford AstraZeneca vaccine, the MHRA being the first regulator to approve a COVID-19 vaccine, vaccinating the first patient, global-leading genomic sequencing, and use of healthcare data that has established treatments saving over a million lives around the world. It is now about bottling the advances that have been made and applying them to the other great health challenges, for the good of all.

    Turning Policies Into Action

    Speaking at this year's 12th Pharmaceutical Industry Network Group (PING) Conference organised by VWV law firm's specialist Pharmaceuticals and Life Sciences sector, and held virtually in conjunction with IQVIA and supported by Hertfordshire Local Enterprise Partnership, Pfizer UK's Country Manager and ABPI President, Ben Osborn, shared his inspirational journey and vision around innovation and collaboration over the last two years. Ben emphasised the importance of having a shared mission and direction, healthcare equitable access, understanding the concept of risk and the need to ensure that science is valued at all levels. In reality, innovation is "all about bringing together science, data and technology" whilst keeping the patient at the heart of it all. Ben stated that "there has never been a more exciting time for life sciences and the opportunity to bring breakthroughs to change patients' lives. The Government's 'Life Sciences Vision' gives a bold ambition, so we must all now partner and translate words into meaningful action."

    The UK Government's 'Life Sciences Vision' published this year provides a 10 year blueprint to act as the key driver for sector growth in the 21st century and keep the UK ahead of the field. The Office for Life Sciences Head of Strategy, Alex Mclaughlin, explained that "the Life Sciences Vision sets out how through working in partnership, Government, NHS, the Sector and academia can create real value for industry and better treatments and technologies for patients. It's an exciting time for life sciences, and the UK is uniquely placed to innovate and lead the way. The Government is determined to work with partners from right across the sector to realise the ambitions of the Vision."

    Building on the NHS Long Term Plan with a focus on population health and working with Integrated Care Systems, the NHS can be a driver for innovation. The Innovative Medicines Fund is another committed Government manifesto to fast-track promising new drugs. Meanwhile, repurposing medicines, as was seen with the discovery within the NHS of the use of the steroid dexamethasone to treat COVID-19 patients during the pandemic, shows what opportunities there are. These are areas that Claire Foreman, Director of Medicines Policy and Strategy at NHS England and Improvement, will be focusing on, to explore what can be done through innovation and also through working with what we already have, thus improving the life sciences sector's delivery of treatments for patients.

    Not only is the Government focusing on UK life sciences plans and policies, it is also prioritising rolling over existing international agreements as well as entering into new ones. Deals with Indo-Pacific life sciences relations including Singapore, Vietnam, Canada and Mexico are being prioritised, while new post-Brexit agreements with Australia and New Zealand are now in place. Andrew Howard, Deputy Director for Trade, Regulation and Analysis at The Office for Life Sciences, talked about the UK's priorities in trade deals, as well as the challenges and opportunities for Britain. He mentioned how "the last few years have been a time of great change, but there are many opportunities for Global Britain in life sciences. The UK has a pioneering regulator, leading academia, a single healthcare system and a strong biopharma sector, as well as a coherent vision for the sector that supports exciting new specialist areas. Having built on existing global relationships, we're now fully focused on nurturing new ones."

    Cultivating Scientific Collaboration

    Collaborations have been important for some time, but the vaccination roll-out has shown how collaborations have come of age. There are more happening, with bigger plans and larger projects. Collaboration is key to accelerating the innovations, and allowing people to benefit from each others' strengths by working together. Relationships are key to a successful collaboration. All stakeholders involved must consider the importance of generosity, have a clear structure and code of practice, and shared vision/values, with an ability to trust and be transparent in sharing knowledge and data.

    CEO of the Institute for Collaborative Working, Claire Ward, stated that "the value of structured collaborative working is having a plan that can support organisations to build sustainable relationships. During COVID-19, the pharmaceutical sector has shown the value of working together; the task now is to embed attitudes and behaviours that can sustain long term collaborative relationships across all parts of the industry."

    From an academia perspective, Pro-Vice Chancellor for Innovation at University of Oxford, Chas Bountra OBE, expressed that "we're facing many global healthcare challenges. No one institution has all the necessary expertise or infrastructure or resources. The only way we are going to tackle these is through collaboration - collaboration amongst universities, with industry, with governments, with regulators, with policy makers and with other countries."

    GlaxoSmithKline's Director Academic Liaison, Malcolm Skingle CBE, also mentioned that "I've seen for years that collaborations are the way to go for pharma - whether with others in pharma or with academia. The pandemic has shown the importance of collaborations. The Vaccine Taskforce achieved their incredible feats through collaborating. Working together to get the best skills together has never been more important."

    VWV's Corporate Partner, Richard Phillips, stated "What a great panel session at the PING 2021 Conference on collaboration with inciteful views on how far it has come, with mindset and attitude instrumental in making collaborative working a success. Getting the contract structure right are tremendously important, though, to ensure parties are clear on their roles and objectives and to plan for the future at the outset. There were some great examples of how effective collaboration can be."

    The Role of Health Data in Drug Discovery

    There has been increased importance placed on genomic and real-world health data in the life sciences sector and working creatively together to manage the data in the most effective and efficient way. The diversity of the data is a key challenge, whilst at the same time decreasing health inequalities. The sector needs to get smarter by looking to work with and check cohorts in other countries globally. It is important to gain and maintain the trust and transparency with all involved and bring the public along to help with health data outcomes. UK Biobank has achieved tremendous things by being a global leader in genomic sequencing, and Our Future Health is a good example of an exciting UK health research programme, to bring people together to develop new ways to detect, prevent and treat diseases.

    Professor Joanne Hackett, Head of Genomic and Precision Medicine at IQVIA, highlighted that "the future for data is a game changer - both genomic and healthcare data. However, the key will be making sure the data is well curated in order to achieve the potential."

    Health Data Research UK's CEO, Caroline Cake, explained how "health data research has enabled some of the most important discoveries about COVID-19 and been a key component of the UK's understanding of and response to the pandemic. There is now a fantastic opportunity to build on this momentum and collaboration in the sector to accelerate our work, making large scale datasets safely available for research, to enable discoveries across the spectrum of health conditions, from cancer to rare diseases."

    Founder & CEO of Genomics PLC, Sir Peter Donnelly, commented how "it's 21 years this year since the announcement of the completion of the draft human genome. I'm now really excited that the field has matured so it can have a major impact on drug discovery and healthcare. It's great to see the UK at the forefront of these opportunities."

    Regulatory

    The COVID-19 vaccine regulators led by the UK's Medicines and Healthcare products Regulatory Agency (MHRA), have also worked in innovative ways to approve medicines much quicker than normal, while not compromising on assessing safety and efficacy. The MHRA is continuing to build on adopting innovation and be seen as a world leading regulator. Dr Kirsty Wydenbach, Expert Medical Assessor at the MHRA, stressed that "the MHRA ambition is about putting patients first, becoming a truly world-leading, enabling regulator and protecting public health through excellence in regulation and science. Support for innovation is a key part of that ambition. We want to hear from researchers and developers early so we can help them stay on track, and so we can learn and become an even more industry-friendly regulator."

    Summing up the PING 2021

    IQVIA's Vice President, Strategic Planning Northern Europe, Angela McFarlane, stated:

    "What a conference. It's left us in no doubt that our next mission as a life science community is to collaborate on the seven 'Healthcare Missions' in the Government Life Sciences Vision, combining the 'best of British' - our unique health data, our world-leading genomics, transformative real world research and innovation in research. If we embrace a mission-led culture in medicines discovery and access, with collaboration being the new norm the UK could become the life sciences."

    VWV's PING Chair and Partner and Head of Pharmaceuticals and Life Sciences sector, Paul Gershlick, concluded:

    "The UK has led the way in so many areas through the pandemic through innovation and collaboration. With a forward-looking life sciences Vision, which gives a clear blueprint for continuing to do that and take a lead in addressing the other great health challenges, including through the strengths of the UK's world class academia, life sciences industry, regulator, and financial centre, Global Britain can continue to be at the hub of leading the way, including in the exciting opportunities through use of health and genomic data."

    Nitin Dahad, Hertfordshire LEP Board Member and Chair, Enterprise and Innovation Board, said:

    "Hertfordshire Local Enterprise Partnership is very proud of its long association with this event - it sends out a clear message that Hertfordshire and the UK is a very attractive place for our diverse life sciences industry to grow. The scale of that global ambition and the clear vision for the future was evidenced in today's hugely exciting programme. We are proud to have played our part in bring considerable investment into the county to support the growth of its world-class cell and gene cluster which was celebrated today."

    For more information about the Pharmaceutical Industry Network Group (PING) and Pharmaceuticals and Life Sciences Law, please contact Paul Gershlick on 07795 570 072 or at pgershlick@vwv.co.uk.

  • 18 Nov 2021 9:06 AM | Adrian Wright (Administrator)

    ICW is at the BSi Conference and Awards today at the Park Lane Hotel Piccadily

Evergreen House North, Grafton Place, Euston, London NW1 2DX . Email: enquiries@icw.uk.com . Phone: 0203 691 1530
Powered by Wild Apricot Membership Software